Hypoxia in cancer chemo- and immunotherapy: foe or friend?
Vitos, N.; Chen, S.; Mathur, S.; Chamseddine, I.; Rejniak, K. A.
Show abstract
Hypoxia, a low level of oxygen in the tissue, is a feature of most solid tumors. It arises due to an imbalance between the oxygen supply from the abnormal vasculature and oxygen demand by the large number of tumor and stromal cells. Hypoxia has been implicated in the development of aggressive tumors and tumor resistance to various therapies. This makes hypoxia a negative marker of patients survival. However, recent advances in designing new hypoxia-activated pro-drugs and adoptive T cell therapies provide an opportunity for exploiting hypoxia in order to improve cancer treatment. We used novel mathematical models of micro-pharmacology and computational optimization techniques for determining the most effective treatment protocols that take advantage of heterogeneous and dynamically changing oxygenation in in vivo tumors. These models were applied to design schedules for a combination of three therapeutic compounds in pancreatic cancers and determine the most effective adoptive T cell therapy protocols in melanomas.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Combining Hypoxia-Activated Prodrugs and Radiotherapy in silico: Impact of Treatment Scheduling and the Intra-Tumoural Oxygen Landscape 96%
- Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine 96%
- Abnormal vasculature reduces overlap between drugs and oxygen in a tumour computational model: implications for therapeutic efficacy 95%
Similar papers in this journal
- A multiscale model of immune surveillance in micrometastases: towards cancer patient digital twins 94%
- Personalized cancer treatment strategies incorporating irreversible and reversible drug resistance mechanisms 94%
- Delaying Cancer Progression by Integrating Toxicity Constraints in a Model of Adaptive Therapy 94%
Similar papers in this journal
- M3NetFlow: A novel multi-scale multi-hop graph AI model for integrative multi-omic data analysis 91%
- A persistent invasive phenotype in post-hypoxic tumor cells is revealed by novel fate-mapping and computational modeling 91%
- Cell Types or Cell States? An Investigation of Adrenergic and Mesenchymal Cell Phenotypes in Neuroblastoma 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.